2016
DOI: 10.1136/ebmed-2015-110359
|View full text |Cite
|
Sign up to set email alerts
|

Colorectal cancer screening is cost-effective in the elderly who have had less intense prior screening, high baseline risk of colorectal cancer and less comorbidities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…114 Screening remains cost-effective in patients into their mid-80s if they have few comorbidities and limited prior screening. 115,116…”
Section: Cost Issuesmentioning
confidence: 99%
“…114 Screening remains cost-effective in patients into their mid-80s if they have few comorbidities and limited prior screening. 115,116…”
Section: Cost Issuesmentioning
confidence: 99%
“…In a large screening trial in 884 patients, capsule colonoscopy had 88% sensitivity for detecting screening ( 114 ). Screening remains cost-eff ective in patients into their mid-80s if they have few comorbidities and limited prior screening ( 115,116 ).…”
Section: Capsule Colonoscopymentioning
confidence: 99%
“…This national programme commenced in 2006, and initially, only people turning 55 and 65 years old each year were invited to participate and sent a kit for faecal occult blood testing (FOBT). In 2008, this programme was extended to people in the year they turned 50 years and in 2013 to people turning 60 years (Jenkins, 2016). From 2015 (after the end of follow-up in this study), the programme was extended to people aged from 50 years up to 74 years.…”
Section: Defining Exposurementioning
confidence: 99%